Brief Title
Study Evaluating Liver Transplantation in Haemophilia Patients in Spain
Official Title
Liver Transplantation in Haemophilia Patients in Spain
Brief Summary
This study will analyze survival and outcome of patients with severe haemophilia who undergo liver transplantation in Spain
Detailed Description
Probability Sample
Study Type
Observational
Primary Outcome
Number of Participants Requiring Immunosuppressive Therapy After Liver Transplantation
Secondary Outcome
Number of Participants Requiring Exogenous Clotting Factor Infusion During Liver Transplantation
Condition
Hemophilia
Intervention
Epidemiological Non interventional
Study Arms / Comparison Groups
Patients with haemophilia who undergo liver transplantation
Description: Patients with haemophilia who underwent liver transplantation and who have been followed up at any site in Spain.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Other
Estimated Enrollment
11
Start Date
July 2009
Completion Date
June 2010
Primary Completion Date
June 2010
Eligibility Criteria
Inclusion Criteria: - Patients with haemophilia who underwent liver transplantation and who have been followed-up at any site in Spain. Exclusion Criteria: - Patients without informed consent form.
Gender
All
Ages
N/A - N/A
Accepts Healthy Volunteers
No
Contacts
Pfizer CT.gov Call Center, ,
Administrative Informations
NCT ID
NCT00927992
Organization ID
B1831011
Secondary IDs
3082B1-4436
Responsible Party
Sponsor
Study Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Study Sponsor
Pfizer CT.gov Call Center, Study Director, Pfizer
Verification Date
December 2012